Temporary or definitive suspensions of clinical trials upon notifications from the Clinical Trials Vigilance Unit of Rennes University Hospital

被引：0
|
作者：
Lefeuvre, C. [1 ]
Mouchel, C. [1 ]
Prioul, A. [1 ]
Polard, E. [1 ]
Bellissant, E. [1 ]
Laviolle, B. [1 ]
机构：
[1] Rennes Univ Hosp, INSERM, Dept Clin Pharmacol, Rennes, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
clinical trial; temporary suspension; definitive suspension; risk-benefit balance; Data Safety Monitoring Board;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-038
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [31] Participation of the pharmaceutical services of the hospitals of the University of Coimbra in the Kidney Transplantation Unit's clinical trials
    Feio, J
    Mota, A
    Cabral, MA
    Martins, MA
    Lemos, L
    Marques, VN
    Roseiro, A
    Portugal, A
    Isabel, O
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (08) : 2685 - 2686
  • [32] Trends in Investigator-Initiated Clinical Studies at a University Hospital after Enforcement of the 2018 Clinical Trials Act in Japan
    Sato, Yasutaka
    Sakaguchi, Satoshi
    Takechi, Kenshi
    Chuma, Masayuki
    Yagi, Kenta
    Kane, Chikako
    Goda, Mitsuhiro
    Hamano, Hirofumi
    Aoe, Yuki
    Nokihara, Hiroshi
    Kubo, Yoshiaki
    Hashimoto, Ichiro
    Yanagawa, Hiroaki
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (03) : 374 - 377
  • [33] Safety activities in study drugs in a public hospital clinical trials unit (IBIS-CTU)
    Jimenez Jorge, S.
    Lobo Acosta, A.
    Lopez Barbazan, E.
    Fresneda Gutierrez, R.
    Garcia Carrera, N.
    Solla Fernandez, M.
    Ibanez Jimenez, B.
    Torrero Soulillou, R.
    Alvarez Rodriguez, L.
    Rosso Fernandez, C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 : 68 - 68
  • [34] Academic clinical trials vigilance activity in six university hospitals in western France: 5-year activity report
    Mouchel, C.
    Boivin, H.
    Carlhant-Kowalsky, D.
    Chiffoleau, A.
    Duranton, S.
    Jamet, A.
    Jobert, A.
    Morvan, F.
    Pinier, M.
    Bellissant, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 20 - 20
  • [35] PAEDIATRICS CLINICAL TRIALS AT THE UNIVERSITY HOSPITAL VALL D'HEBRON (PERIOD 2004-2011)
    Cucurull, E.
    Rodriguez, A.
    Ramio, X.
    Fuentes, I
    Navarro, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 : 13 - 13
  • [36] Serious adverse events occurring during clinical trials: a French university hospital promotor experience
    Llau, M. E.
    Roques, N.
    Cantagrel, A.
    Montastruc, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 70 - 70
  • [37] Overview of clinical trials vigilance units in French institutional sponsors - A study from the REVISE working group
    Petitpain, Nadine
    Olivier, Pascale
    Crepin, Sabrina
    Leone, Emanuela
    Ouk, Thavarak
    Villeneuve, Claire
    Muller, Charlotte
    Ruault, Sophie
    Jamet, Aurelie
    Franceschi, Marie-Paule
    Duranton, Sophie
    Gavard, Marylaure
    THERAPIE, 2021, 76 (06): : 743 - 750
  • [38] Hospital-acquired pneumonia: diagnostic strategies: lessons from clinical trials
    Fagon, JY
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2003, 17 (04) : 717 - +
  • [39] Participation of patients in clinical trials at the Ramon y Cajal Hospital Phase I Clinical Trial Unit: perception and degree of satisfaction
    Galvez Mugica, Maria Angeles
    San Andres Munoz, Jose Daniel
    Lopez Algarra, Isabel
    Lopez de Abechuco, Itziar de Pablo
    Aguilar Jimenez, Monica
    Sanchez Espada, Ana Isabel
    del Alamo Camunas, Marta
    Serrano Olmeda, Maria Luisa
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 26 - 27
  • [40] Which Obstacles Prevent Us from Recruiting into Clinical Trials: A Survey about the Environment for Clinical Studies at a German University Hospital in a Comprehensive Cancer Center
    Straube, Christoph
    Herschbach, Peter
    Combs, Stephanie E.
    FRONTIERS IN ONCOLOGY, 2017, 7
12345